Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker

[1]  A. Giordano,et al.  Nuclear and cytoplasmic interaction of pRb2/p130 and ER-β in MCF-7 breast cancer cells , 2006 .

[2]  D. Xie,et al.  Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma , 2005, British Journal of Cancer.

[3]  D. Eisenberg,et al.  A survivin gene signature predicts aggressive tumor behavior. , 2005, Cancer research.

[4]  Kouji Matsumoto,et al.  Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index , 2005, Journal of Neuro-Oncology.

[5]  D. Tan,et al.  Nuclear or cytoplasmic expression of survivin: What is the significance? , 2005, International journal of cancer.

[6]  Mian Wu,et al.  Identification of a novel nucleolar localization signal and a degradation signal in Survivin-deltaEx3: a potential link between nucleolus and protein degradation , 2005, Oncogene.

[7]  P. Korkolopoulou,et al.  Apoptotic markers for primary brain tumor prognosis , 2005, Journal of Neuro-Oncology.

[8]  M. P. Holloway,et al.  Survivin splice variants regulate the balance between proliferation and cell death , 2005, Oncogene.

[9]  H. Caldas,et al.  Survivin 2α: a novel Survivin splice variant expressed in human malignancies , 2005, Molecular Cancer.

[10]  F. Li,et al.  Role of survivin and its splice variants in tumorigenesis , 2004, British Journal of Cancer.

[11]  G. Giaccone,et al.  Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  C. Cohen,et al.  Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome , 2004, Modern Pathology.

[13]  A. Grosu,et al.  Radiotherapy for High-Grade Gliomas , 2004, Strahlentherapie und Onkologie.

[14]  G. Rassidakis,et al.  Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  F. Bosch,et al.  Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival. , 2004, The American journal of pathology.

[16]  K. Shroyer,et al.  Survivin expression in human osteosarcoma is a marker for survival. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  L. O’Driscoll,et al.  Prognostic importance of survivin in breast cancer , 2003, British Journal of Cancer.

[18]  H. Stein,et al.  Prognostic value of nuclear survivin-expression in esophageal squamous cell carcinoma , 2003 .

[19]  F. Yamasaki,et al.  Expression of survivin in astrocytic tumors , 2003, Cancer.

[20]  H. Stein,et al.  Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma , 2003, British Journal of Cancer.

[21]  E. Blomquist,et al.  A Systematic Overview of Radiation Therapy Effects in Brain Tumours , 2003, Acta oncologica.

[22]  C. Suschek,et al.  Differential subcellular localization of functionally divergent survivin splice variants , 2002, Cell Death and Differentiation.

[23]  G. Giaccone,et al.  CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin. , 2002, Experimental cell research.

[24]  L. Stewart,et al.  Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials , 2002, The Lancet.

[25]  P. Black,et al.  Quantitatively determined survivin expression levels are of prognostic value in human gliomas. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Y. Takano,et al.  Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. , 2001, Cancer letters.

[27]  D. Altieri,et al.  Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. , 1998, Cancer research.

[28]  A. Giordano,et al.  Nuclear and cytoplasmic interaction of pRb2/p130 and ER-beta in MCF-7 breast cancer cells. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  A. Grosu,et al.  Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome? , 2004, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[30]  田中 慶太朗,et al.  Expression of survivin and its relationship to loss of apoptosis in breast carcinomas , 2000 .